 Valerie Minarchick
Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 6 | 2019 | 481 | 0.880 |
Why?
| | Cerium | 2 | 2014 | 17 | 0.860 |
Why?
| | Vasodilation | 3 | 2014 | 512 | 0.690 |
Why?
| | Arterioles | 3 | 2014 | 57 | 0.560 |
Why?
| | Coronary Vessels | 3 | 2015 | 246 | 0.470 |
Why?
| | Mesentery | 1 | 2014 | 45 | 0.440 |
Why?
| | Mesenteric Arteries | 1 | 2013 | 17 | 0.420 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2014 | 258 | 0.380 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2014 | 445 | 0.380 |
Why?
| | Titanium | 4 | 2019 | 85 | 0.380 |
Why?
| | Extracellular Traps | 2 | 2023 | 53 | 0.370 |
Why?
| | Particulate Matter | 3 | 2015 | 330 | 0.250 |
Why?
| | Lung | 3 | 2019 | 4051 | 0.240 |
Why?
| | Rats, Sprague-Dawley | 7 | 2015 | 2511 | 0.230 |
Why?
| | Reactive Oxygen Species | 5 | 2019 | 630 | 0.210 |
Why?
| | Microcirculation | 3 | 2013 | 137 | 0.200 |
Why?
| | Antiphospholipid Syndrome | 1 | 2023 | 31 | 0.200 |
Why?
| | Signal Transduction | 2 | 2019 | 5116 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2014 | 2047 | 0.170 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 125 | 0.160 |
Why?
| | Granulocyte Precursor Cells | 1 | 2019 | 10 | 0.160 |
Why?
| | Zinc Oxide | 1 | 2019 | 9 | 0.160 |
Why?
| | Sputum | 1 | 2021 | 310 | 0.160 |
Why?
| | Silver | 1 | 2019 | 38 | 0.150 |
Why?
| | Environmental Exposure | 3 | 2019 | 579 | 0.150 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 111 | 0.150 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 85 | 0.150 |
Why?
| | Neutrophils | 2 | 2023 | 1113 | 0.140 |
Why?
| | Toxicity Tests | 2 | 2019 | 39 | 0.140 |
Why?
| | Particle Size | 2 | 2019 | 403 | 0.130 |
Why?
| | Animals | 14 | 2023 | 37328 | 0.120 |
Why?
| | Administration, Inhalation | 2 | 2014 | 594 | 0.120 |
Why?
| | Chromium | 1 | 2015 | 16 | 0.120 |
Why?
| | Rats | 8 | 2015 | 5556 | 0.120 |
Why?
| | Air Pollutants, Occupational | 1 | 2015 | 41 | 0.110 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.110 |
Why?
| | Cadmium | 1 | 2015 | 68 | 0.110 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 38 | 0.110 |
Why?
| | Mitochondrial Diseases | 1 | 2015 | 94 | 0.110 |
Why?
| | Cyclic GMP | 1 | 2014 | 91 | 0.110 |
Why?
| | Microvessels | 1 | 2015 | 86 | 0.110 |
Why?
| | Injections, Intravenous | 1 | 2014 | 202 | 0.110 |
Why?
| | Intubation, Gastrointestinal | 1 | 2014 | 77 | 0.110 |
Why?
| | Endothelial Cells | 1 | 2019 | 816 | 0.100 |
Why?
| | Organ Culture Techniques | 1 | 2013 | 157 | 0.100 |
Why?
| | Trachea | 1 | 2015 | 250 | 0.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 207 | 0.100 |
Why?
| | Coal Mining | 1 | 2013 | 24 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1184 | 0.090 |
Why?
| | Busulfan | 1 | 2012 | 15 | 0.090 |
Why?
| | Vasoconstriction | 1 | 2013 | 215 | 0.090 |
Why?
| | Nanotubes, Carbon | 1 | 2012 | 48 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 337 | 0.090 |
Why?
| | Administration, Oral | 1 | 2014 | 825 | 0.090 |
Why?
| | Mitochondria | 2 | 2015 | 962 | 0.090 |
Why?
| | Endothelium, Vascular | 3 | 2013 | 943 | 0.090 |
Why?
| | Nanostructures | 1 | 2013 | 114 | 0.090 |
Why?
| | Macrophages | 1 | 2019 | 1478 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 32 | 0.090 |
Why?
| | Air Pollution | 1 | 2015 | 321 | 0.090 |
Why?
| | Pneumonia | 2 | 2015 | 634 | 0.090 |
Why?
| | Hydroxyl Radical | 1 | 2012 | 95 | 0.090 |
Why?
| | Alanine | 1 | 2012 | 159 | 0.090 |
Why?
| | Maternal Exposure | 1 | 2013 | 201 | 0.080 |
Why?
| | Glutathione | 1 | 2012 | 361 | 0.080 |
Why?
| | Vascular Diseases | 1 | 2013 | 244 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1490 | 0.080 |
Why?
| | Nitric Oxide | 1 | 2014 | 894 | 0.080 |
Why?
| | Liver | 2 | 2015 | 1821 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2015 | 656 | 0.070 |
Why?
| | Fetus | 1 | 2013 | 797 | 0.070 |
Why?
| | Epithelial Cells | 1 | 2014 | 1105 | 0.070 |
Why?
| | Air Pollutants | 1 | 2013 | 428 | 0.070 |
Why?
| | Oxidative Stress | 3 | 2019 | 1327 | 0.070 |
Why?
| | Male | 9 | 2021 | 70140 | 0.060 |
Why?
| | Apoptosis | 3 | 2019 | 2487 | 0.060 |
Why?
| | Adenylate Kinase | 1 | 2023 | 27 | 0.050 |
Why?
| | Interleukin-6 | 2 | 2019 | 775 | 0.050 |
Why?
| | Hydrogen Peroxide | 2 | 2015 | 334 | 0.050 |
Why?
| | Mice | 4 | 2023 | 17969 | 0.050 |
Why?
| | Plant Extracts | 1 | 2023 | 209 | 0.040 |
Why?
| | Cell Degranulation | 1 | 2019 | 41 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 49 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2019 | 113 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2019 | 74 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2091 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2019 | 221 | 0.040 |
Why?
| | Solubility | 1 | 2019 | 239 | 0.040 |
Why?
| | Surface Properties | 1 | 2019 | 412 | 0.040 |
Why?
| | Phagocytosis | 1 | 2019 | 291 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2019 | 351 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2019 | 558 | 0.030 |
Why?
| | Cell Survival | 1 | 2019 | 1123 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 854 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2015 | 126 | 0.030 |
Why?
| | Injections, Spinal | 1 | 2015 | 108 | 0.030 |
Why?
| | Cell Respiration | 1 | 2015 | 106 | 0.030 |
Why?
| | Tungsten Compounds | 1 | 2015 | 3 | 0.030 |
Why?
| | Toxicity Tests, Acute | 1 | 2015 | 8 | 0.030 |
Why?
| | Cobalt | 1 | 2015 | 51 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 92 | 0.030 |
Why?
| | Uterine Artery | 1 | 2015 | 75 | 0.030 |
Why?
| | Caspases | 1 | 2015 | 244 | 0.030 |
Why?
| | Mechanotransduction, Cellular | 1 | 2015 | 116 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 298 | 0.030 |
Why?
| | Humans | 5 | 2023 | 141284 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2863 | 0.030 |
Why?
| | Uterine Contraction | 1 | 2013 | 18 | 0.020 |
Why?
| | Splanchnic Circulation | 1 | 2013 | 12 | 0.020 |
Why?
| | Appalachian Region | 1 | 2013 | 18 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 757 | 0.020 |
Why?
| | Environmental Monitoring | 1 | 2015 | 369 | 0.020 |
Why?
| | Dilatation, Pathologic | 1 | 2012 | 61 | 0.020 |
Why?
| | Nitroprusside | 1 | 2012 | 72 | 0.020 |
Why?
| | Phenylephrine | 1 | 2012 | 75 | 0.020 |
Why?
| | Echocardiography | 1 | 2015 | 647 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1761 | 0.020 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 33 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2013 | 134 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2015 | 712 | 0.020 |
Why?
| | DNA Damage | 1 | 2015 | 430 | 0.020 |
Why?
| | Inhalation Exposure | 1 | 2013 | 113 | 0.020 |
Why?
| | Glutathione Transferase | 1 | 2012 | 99 | 0.020 |
Why?
| | Biocatalysis | 1 | 2012 | 69 | 0.020 |
Why?
| | Aerosols | 1 | 2013 | 177 | 0.020 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2012 | 97 | 0.020 |
Why?
| | Acetylcholine | 1 | 2012 | 204 | 0.020 |
Why?
| | Metals | 1 | 2013 | 140 | 0.020 |
Why?
| | Uterus | 1 | 2013 | 221 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 132 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 2079 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 522 | 0.020 |
Why?
| | Organ Size | 1 | 2012 | 476 | 0.020 |
Why?
| | Microscopy | 1 | 2013 | 156 | 0.020 |
Why?
| | Pregnancy | 2 | 2015 | 7035 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 452 | 0.020 |
Why?
| | Iron | 1 | 2012 | 324 | 0.020 |
Why?
| | Fetal Development | 1 | 2013 | 296 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1220 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 633 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 565 | 0.020 |
Why?
| | Heart | 1 | 2012 | 616 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1620 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 593 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2012 | 1080 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4180 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 560 | 0.020 |
Why?
| | Myocardium | 1 | 2012 | 911 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10490 | 0.020 |
Why?
| | Female | 3 | 2021 | 75814 | 0.010 |
Why?
| | Kidney | 1 | 2012 | 1482 | 0.010 |
Why?
| | Inflammation | 1 | 2015 | 2840 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6951 | 0.010 |
Why?
|
|
Minarchick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|